Managing checkpoint inhibitor immunotherapy refills requires careful monitoring for immune-related adverse events (irAEs) that can affect multiple organ systems. This Immunotherapy Checkpoint Inhibitor Refill Request Form helps oncology practices, infusion centers, and specialty pharmacies streamline the refill process while ensuring comprehensive safety screening and appropriate specialty collaboration.

Why this form matters for oncology teams

Checkpoint inhibitors have revolutionized cancer treatment, but their unique mechanism—unleashing the immune system—means patients require vigilant monitoring between cycles. This template creates a structured workflow that captures essential clinical information, identifies concerning symptoms early, and facilitates rapid communication between oncology and rheumatology or other specialty teams when immune-related complications arise.

Key features for immunotherapy management

The form includes targeted screening questions for common irAEs across dermatologic, gastrointestinal, hepatic, endocrine, pulmonary, and rheumatologic systems. It captures current corticosteroid use and bridging protocols, documents performance status changes, and flags patients who may need specialty consultation before their next infusion. Conditional logic ensures that concerning responses trigger additional detail capture and appropriate care team notifications.

Seamless integration with your oncology workflow

Connect this form to your electronic health records, pharmacy systems, and team communication tools using Stepper (stepper.io) to automate refill approvals, specialty referrals, and patient follow-up scheduling. Route flagged submissions to nurse navigators or physicians for review, update treatment logs automatically, and send patients customized instructions based on their screening results—all without manual data entry.

Designed for medical oncologists, hematology-oncology practices, infusion centers, specialty pharmacies, and multidisciplinary cancer care teams, this form brings structure and safety to one of modern oncology's most powerful—and complex—treatment modalities.